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Abstract
Mitochondrial shape is determined by fission and fusion reactions catalyzed by large GTPases of the dynamin family,
mutation of which can cause neurological dysfunction. While fission-inducing protein phosphatases have been identified,
the identity of opposing kinase signaling complexes has remained elusive. We report here that in both neurons and non-
neuronal cells, cAMP elevation and expression of an outer-mitochondrial membrane (OMM) targeted form of the protein
kinase A (PKA) catalytic subunit reshapes mitochondria into an interconnected network. Conversely, OMM-targeting of the
PKA inhibitor PKI promotes mitochondrial fragmentation upstream of neuronal death. RNAi and overexpression approaches
identify mitochondria-localized A kinase anchoring protein 1 (AKAP1) as a neuroprotective and mitochondria-stabilizing
factor in vitro and in vivo. According to epistasis studies with phosphorylation site-mutant dynamin-related protein 1 (Drp1),
inhibition of the mitochondrial fission enzyme through a conserved PKA site is the principal mechanism by which cAMP and
PKA/AKAP1 promote both mitochondrial elongation and neuronal survival. Phenocopied by a mutation that slows GTP
hydrolysis, Drp1 phosphorylation inhibits the disassembly step of its catalytic cycle, accumulating large, slowly recycling
Drp1 oligomers at the OMM. Unopposed fusion then promotes formation of a mitochondrial reticulum, which protects
neurons from diverse insults.
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Introduction
Opposing fission and fusion events determine the shape and
interconnectivity of mitochondria to regulate various aspects of
their function, including ATP production, Ca
++ buffering, free
radical homeostasis, mitochondrial DNA inheritance, and organ-
elle quality control. In addition, fragmentation of neuronal
mitochondria is necessary for their transport to and proper
development and function of synapses. Moreover, mitochondrial
fission is an early step in the mitochondrial apoptosis pathway, and
inhibiting fission can block or delay apoptosis in a variety of cell
types, including neurons [1–3].
Fission and fusion processes are catalyzed by large GTPases of
the dynamin superfamily. Mitochondrial fission requires dynamin-
related protein 1 (Drp1), which, similar to the ‘‘pinchase’’
dynamin, is thought to mechanically constrict and eventually
sever mitochondria. Normally a largely cytosolic protein, Drp1 is
recruited to the outer mitochondrial membrane (OMM) by a
poorly characterized multiprotein complex that includes the
transmembrane proteins Fis1 and Mff [4–6]. Mitochondrial fusion
is carried out by the concerted action of OMM-anchored GTPases
(mitofusin-1 and -2 in vertebrates) and optic atrophy 1 (Opa1), a
GTPase localized to the intermembrane space [4]. A properly
controlled fission/fusion balance appears to be particularly critical
in neurons, since mutations in mitochondrial fission/fusion
enzymes are responsible for common neurological disorders in
humans [7–10]. All mitochondria-restructuring enzymes are
essential for mammalian development, as mice that lack Drp1,
Opa1, or either of the two mitofusins die during early
embryogenesis [11–14].
Our understanding of the signaling events that regulate this
group of organelle shaping GTPases is limited. Drp1, in particular,
is subject to complex posttranslational modification by ubiquityla-
tion, sumoylation, nitrosylation, and phosphorylation [15,16].
Highly conserved among metazoan Drp1 orthologs, the two
characterized serine phosphorylation sites are located 20 amino
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(GED). Since the numbering differs between Drp1 orthologs and
splice variants, we will refer to these sites by the kinase first shown
to target them, rather than their sequence number. SerCDK
(Ser616 in human, Ser635 in rat splice variant 1) is phosphorylated
by the cyclin-dependant kinase 1/cyclin B complex, leading to
fragmentation of the mitochondrial network during mitosis.
Phosphorylation of SerPKA (Ser637 in human, Ser656 in rat splice
variant 1) is mediated by both PKA and Ca
2+/calmodulin-
dependent protein kinase I (CaMKI). Three laboratories,
including ours, found that SerPKA phosphorylation by PKA
promotes mitochondrial elongation presumably through Drp1
inhibition [17–19], whereas a fourth group reported the opposite
effect upon targeting of the same site by CaMKI [20].
We previously showed that Bb2, a neuron-specific and OMM-
targeted regulatory subunit of protein phosphatase 2A (PP2A),
sensitizes neurons to various insults by promoting mitochondrial
fission [21]. Here, we identify outer mitochondrial PKA as the
opposing fusion and survival promoting kinase. Evidence for a
model is presented in which the multifunctional scaffold protein
AKAP1 recruits PKA to the OMM to phosphorylate Drp1 at
SerPKA. Phosphorylation traps Drp1 in large, slowly recycling
complexes, allowing mitochondria to fuse into a neuroprotective
reticulum.
Results
cAMP and Outer Mitochondrial PKA Activity Promote
Mitochondrial Elongation
In an effort to identify signal transduction pathways that alter
the mitochondrial fission/fusion balance, we investigated the effect
of elevating cAMP levels in PC12 pheochromocytoma cells and
primary hippocampal neurons. Mitochondria were visualized by
transfection with mitochondria-targeted GFP or by live-staining
with the fluorescent dye MitoTracker Red. Application of the
adenylate cyclase agonist forskolin either alone or in combination
with the phosphodiesterase type IV inhibitor rolipram resulted in
the conversion of mostly punctiform or short and stubby
mitochondria to highly elongated and interconnected organelles
(Figure 1A–D). Mitochondrial shape changes were quantified by
image analysis [22] as well as by blinded comparison to a set of
reference images (length score 0 to 4; Figure S1A; [21]). Both
methods yielded comparable elongation measures that correlated
on a cell-by-cell basis (Figure S1B, C, and D). Mitochondrial
elongation was readily apparent within 30 min of forskolin
addition and was insensitive to inhibition of protein synthesis by
cycloheximide, which together suggests non-genomic actions of
cAMP (Figure 1B). Mitochondrial elongation mediated by
forskolin or the membrane permeable cAMP analog cpt-cAMP
lasted for at least 20 h in PC12 cells and in the soma of
hippocampal neurons (Figure 1C,D).
To implicate PKA in the morphogenetic effects of cAMP, we
established clonal PC12 cell lines that inducibly express the PKA
inhibitory peptide PKI fused to GFP and the outer mitochondrial
anchor domain of MAS70p (omPKI). Cells with inducible
expression of an OMM-directed form of the protein phosphatase
1 (PP1) modulator inhibitor-2 (omInh2) were analyzed for
comparison (Figure 2A). Induction of omPKI by doxycycline
resulted in mitochondrial fragmentation, measured both by
subjective scoring and image analysis. Conversely, mitochondria
decorated with the PP1 inhibitor were significantly elongated
compared to mitochondria of uninduced cells (Figure 2B–D).
Given that mitochondrial fragmentation is associated with
apoptotic and non-apoptotic cell death [2,3], we examined cell
lines expressing mitochondria-targeted PP1 and PKA inhibitors
for their susceptibility to apoptotic stressors. Inhibition of neither
outer mitochondrial PP1 nor PKA affected survival or growth of
PC12 cells under basal conditions (Figure 2F and unpublished
data). In contrast, induction of omPKI was associated with
increased sensitivity to several apoptosis inducers, including H2O2
and staurosporine (Figure 2E,F). These results indicate that PKA
activity at the mitochondrial surface opposes fragmentation of this
organelle and increases resistance to apoptosis inducers.
PKA/AKAP1 Supports Neuronal Survival and
Mitochondrial Network Integrity
AKAPs recruit the PKA holoenzyme to specific subcellular sites
and substrates, which is critical for the physiological actions of the
kinase [23]. Of the three AKAPs that have been localized to
mitochondria, the OMM-anchored AKAP1 (also known as D-
AKAP1, AKAP121, AKAP149) has previously been shown to
enhance survival in PC12 cells [24]. We expressed AKAP1-GFP in
hippocampal neurons and scored apoptosis either under basal
conditions or 2 d after treatment with rotenone, an inhibitor of
complex 1 of the electron transport chain that is commonly used as
a chemical model of Parkinson’s disease. Wild-type AKAP1, but
not a point mutant that cannot bind the PKA holoenzyme
(AKAP1DPKA = I310P, L316P; Figure S2A), had a potent
neuroprotective effect under both conditions (Figure 3A). Con-
versely, knockdown of endogenous AKAP1 with two different
shRNAs (Figure S2B,C) dramatically amplified both basal and
rotenone-induced neuronal death (Figure 3A). Additionally, as we
observed in stressed PC12 cells, inhibiting outer mitochondrial
PKA by expressing omPKI resulted in increased basal apoptosis in
hippocampal neurons. Thus, AKAP1 enhances neuronal survival
by recruiting PKA to the OMM. Our finding that AKAP1 and
outer mitochondrial PKA are critical for neuronal viability
contrasts with the mild phenotypes seen in unconditional AKAP1
knockout mice [25]. It is possible that other mitochondrial AKAPs
may be able to compensate if AKAP1 is never expressed.
To investigate whether the pro-survival effects of PKA/AKAP1
are associated with changes in mitochondrial morphology,
Author Summary
Mitochondria, the cellular powerhouse, are highly dynamic
organelles shaped by opposing fission and fusion events.
Research over the past decade has identified many
components of the mitochondrial fission/fusion machinery
and led to the discovery that mutations in genes coding
for these proteins can cause human neurological diseases.
While it is well established that mitochondrial shape
changes are intimately involved in cellular responses to
environmental stressors, we know very little about the
mechanisms by which cells dynamically adjust mitochon-
drial form and function. In this report, we show that the
scaffold protein AKAP1 brings the cAMP-dependent
protein kinase PKA to the outer mitochondrial membrane
to protect neurons from injury. The PKA/AKAP1 complex
functions by inhibiting Drp1, an enzyme that mechanically
constricts and eventually severs mitochondria. Whereas
active, dephosphorylated Drp1 rapidly cycles between
cytosol and mitochondria, phosphorylated Drp1 builds up
in inactive mitochondrial complexes, allowing mitochon-
dria to fuse into a neuroprotective reticulum. Our results
suggest that altering the balance of kinase and phospha-
tase activities at the outer mitochondrial membrane may
provide the basis for novel neuroprotective therapies.
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PLoS Biology | www.plosbiology.org 2 April 2011 | Volume 9 | Issue 4 | e1000612Figure 2. Inducible inhibition of outer mitochondrial PKA antagonizes mitochondrial fusion and survival. (A) Lysates of clonal PC12 cell
lines (clone numbers listed) expressing outer-mitochondrial GFP-PKI (omPKI) or GFP-inhibitor-2 (omInh2) from a doxycycline (Dox)-inducible
promoter were treated 6 Dox (1 mg/ml, 48 h) or forskolin (forsk, 10 mM, 2 h) and immunoblotted for GFP, PKA substrates (RXX[pS/pT] antibody), and
PP2A/C as a loading control. (B–D) PC12::omPKI and omInh2 cells were analyzed for mitochondrial morphology 6 Dox induction for 2 d
(representative confocal images of live cells stained with TMRM (B), reference image based length scores in (C), and digital morphometry in (D) of the
same set of 31–38 cells). (E, F) PC12 cell lines were treated 6 Dox for 2 d to induce omPKI or omInh2, followed by a 2 d challenge with staurosporine
or H2O2. In (E), viability was scored by a colorimetric assay (tetrazolium reduction to formazan), while apoptotic nuclei were counted in (F). Bar graphs
show means 6 S.E.M. and are representative of at least three independent experiments. Student’s t test comparisons are between 6 Dox-treated
cultures.
doi:10.1371/journal.pbio.1000612.g002
Figure 1. PKA activators rapidly induce mitochondrial fusion. TMRM or MitoTracker-stained PC12 cells (A–C) or hippocampal neurons (D)
were treated for the indicated times with either vehicle or the listed compounds and mitochondrial morphology was quantified by blinded
comparison to reference images (B–D, means 6 S.E.M.). (A) Representative epifluorescence images show formation of interconnected mitochondria
upon treatment of PC12 cells with forskolin/rolipram (forsk/roli, 20 mM/1 mM, 3 h). In the representative experiment shown in (B), rapid mitochondrial
elongation by 50 mM forskolin is not affected by 100 mg/ml cycloheximide to inhibit protein synthesis. Long-term (20 h) forskolin or a cell-permeant
cAMP analog (200 mM cpt-cAMP) promotes mitochondrial fusion in PC12 cells (C) and hippocampal neurons (D); summaries of three independent
experiments with 20–30 cells per condition are shown.
doi:10.1371/journal.pbio.1000612.g001
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PLoS Biology | www.plosbiology.org 3 April 2011 | Volume 9 | Issue 4 | e1000612Figure 3. Mitochondrial PKA and AKAP1 promote neuronal survival and oppose mitochondrial fragmentation in vitro and in vivo.
(A) Hippocampal neurons were transfected with the indicated cDNA and shRNA plasmids (AKAP1DPKA = I310P,L316P [PKA binding defective];
Figure S2C). After 3 d, cells were treated 6 400 nM rotenone for 2 d, fixed, and analyzed by counting apoptotic nuclei in the transfected neuron
population (means 6 s.e.m. of n=3–7 experiments). The inset shows two transfected neurons (green) with apoptotic nuclei and an untransfected
neuron with normal nucleus (asterisk). (B, C) Representative confocal sections of TMRM-stained (mito) hippocampal neurons (B) and their
mitochondrial length scores (C) 3 d after transfection with the indicated cDNA and shRNA constructs are shown (means 6 s.e.m. of n=3–5
experiments; Student’s t test comparisons between GFP fusion proteins and omGFP and between AKAP1 and NS shRNAs). (D–F) Rats injected with
lentivirus expressing mitochondrial (m)GFP and AKAP1-GFP into the hippocampus and striatum of left and right hemispheres, respectively, were
analyzed 7–14 d later for mitochondrial shape. Perfusion-fixed cryostat sections immunolabeled for GFP (representative confocal image in (D),
counterstained for nuclei with TOPRO-3 [blue]) were subjected to ImageJ software-based morphometry. Scatter plots (E, F) correlate form factor
(inverse of circularity of individual mitochondria) with cumulative area:perimeter ratio (a measure of network connectivity). Each open symbol
represents average shape metrics from 10–22 z-sections of one neuron; filled symbols are population averages (6 s.d., 29–42 neurons per condition
from 2 (E) and 3 (F) rats).
doi:10.1371/journal.pbio.1000612.g003
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imaged 2–3 d after transfection. As previously reported in other
cell types [26], AKAP1-GFP colocalized perfectly with mitochon-
dria in hippocampal neurons (Figure 3B). Compared to OMM-
targeted GFP or the AKAP1 mutant that cannot recruit PKA,
overexpression of wild-type AKAP1 increased mitochondrial
length scores in the somal mitochondria (Figure 3B,C). AKAP1
expression also increased mitochondrial form factor in dendrites of
hippocampal neurons (Figure S3A,B). Targeting the PKA catalytic
subunit directly to the OMM (omPKA) resulted in even more
striking mitochondrial fusion, often culminating in perinuclear
aggregation of mitochondria into a single mass. Conversely, either
expression of OMM-tethered PKI or silencing of AKAP1 with two
shRNAs induced significant somatic mitochondrial fragmentation
as compared to OMM-targeted GFP and nonsense shRNA
controls (Figure 3C). AKAP1 knockdown also induced mitochon-
drial fragmentation in dendrites of hippocampal neurons (Figure
S3A,B). To rule out off-target effects, we silenced the endogenous
protein in PC12 cells by co-expression of rat AKAP1-directed
shRNAs with or without plasmids encoding human AKAP1,
which diverges at both shRNA target sites. Human AKAP1
reversed the mitochondrial fragmentation induced by rat AKAP1-
directed shRNAs (Figure S4A,B), indicating that loss of mito-
chondrial interconnectivity is due to specific silencing of the
endogenous protein.
AKAP1 Expression Leads to Mitochondrial Elongation In
Vivo
Lentivirus expressing AKAP1-GFP was stereotaxically injected
into the right striatum and hippocampus of rats; the left
hemisphere received injections with a control lentivirus encoding
mitochondrial (m)GFP (targeted via the N terminus of cytochrome
oxidase VIII). After 7–14 d, mitochondrial shape was assessed by
automated morphometry of confocal z-stacks from perfusion-fixed
brain sections (Figure 3D). Compared to mGFP, lentiviral delivery
of AKAP1 into the hippocampus and striatum induced robust
mitochondrial fusion as indicated by two independent metrics,
form factor, which measures elongation of individual mitochon-
dria, and cumulative area:perimeter ratio, which measures
mitochondrial interconnectivity (Figure 3E,F). Thus, neuroprotec-
tion by PKA/AKAP1 is associated with mitochondrial elongation
both in vitro and in vivo.
PKA-Induced Mitochondrial Remodeling Determines
Neuronal Survival
We carried out epistasis experiments in hippocampal neurons to
determine whether PKA-mediated changes in mitochondrial
shape and neuronal survival are causally related. Initially, we
showed that overexpression of the antiapoptotic Bcl2 protein
prevented apoptosis induced by inhibiting PKA with omPKI but
had no effect on omPKI-induced mitochondrial fragmentation
(Figure 4A,B). Similarly, Bcl2 rescued neurons from apoptosis due
to AKAP1 silencing without restoring normal mitochondrial
morphology (Figure S5). Therefore, mitochondrial fragmentation
due to PKA inhibition occurs either independently of or upstream
of apoptosis.
To distinguish between these possibilities, we interfered with
mitochondrial fission by dominant-negative (K38A mutant) Drp1
or Fis1 knockdown. Blocking the mitochondrial fission machinery
fully restored viability of neurons transfected with omPKI,
demonstrating that PKA inhibition kills by inducing mitochondrial
fission. In contrast, AKAP1 silencing with two shRNAs compro-
mised neuronal viability in a manner that could not be reversed by
inhibiting mitochondrial fission (Figure S5). Our data thus point to
an essential function of AKAP1 beyond localizing PKA to
maintain mitochondrial integrity. In this regard, the AKAP1 gene
gives rise to multiple splice variants, which have been localized to
the endoplasmatic reticulum and nuclear lamina, in addition to
mitochondria. Also, AKAP1 interacts not only with PKA but also
with various other signaling enzymes and mRNA [26].
The data thus far suggest a model in which the cAMP signaling
through the outer mitochondrial PKA/AKAP1 complex opposes
the mitochondria fragmenting activity of several protein phospha-
tases including PP2A [21], PP2B/calcineurin [17,18], and likely
PP1 (Figure 2C,D). Kinase/phosphates-regulated mitochondrial
shape changes control neuronal vulnerability to a variety of
challenges (Figure 4C).
PKA/AKAP1 Slows Turnover of Mitochondrial Drp1
PKA/AKAP1 could maintain elongated mitochondria by
inhibiting fission or promoting fusion reactions. The mitochon-
drial fission enzyme Drp1 was previously shown to be phosphor-
ylated by PKA and phospho-mimetic substitution of the targeted
Ser residue causes mitochondrial elongation [18,19]. We therefore
examined the mobility of Drp1 by fluorescence recovery after
photobleaching (FRAP), replacing endogenous Drp1 in PC12 cells
with the GFP-tagged protein by a single-plasmid RNAi/expression
strategy (Figure S2D) [18]. Similar to the endogenous fission
enzyme, GFP-Drp1 was localized diffusely in the cytosol, as well as
in punctate structures on mitochondria (Figure 5A). Fluorescence
recovery of mitochondrial GFP-Drp1 could be well approximated
by double exponential fits (R
2.0.99) and was largely independent
of the size of the bleached area, indicating that Drp1 mobility
follows reaction- rather than diffusion-limited kinetics [27]. Drp1
fluorescence recovery was also shown to be unaffected by prior
fragmentation of mitochondria via protonophore treatment
(Figure S6), indicating that Drp1 turnover determines mitochon-
drial shape and not vice versa.
Silencing of AKAP1 increased the cytosolic pool at the expense
of the mitochondrial pool of GFP-Drp1 and accelerated
fluorescence recovery of mitochondrial GFP-Drp1. Activation of
PKA by forskolin/rolipram treatment had the opposite effect,
increasing mitochondrial localization of GFP-Drp1 and slowing its
turnover (Figure 5B,C). Faster Drp1 recovery was reflected in an
increase in the plateau of the double exponential fit (mobile
fraction) and a decrease in the 50% recovery time constant (t1/2);
therefore, we expressed Drp1 turnover as the ratio of the two
curve-fitting parameters (Figure 5D).
In support of the imaging experiments, subcellular fractionation
of GFP-Drp1 expressed in COS cells showed that 80% of the
fission protein is cytosolic, while 20% localizes to a heavy
membrane fraction that includes mitochondria (Figure 5E,F).
Co-expression of OMM-targeted PKA catalytic subunit induced
phosphorylation of Drp1 SerPKA mainly in the mitochondrial
fraction as detected with a phosphorylation state-specific antibody.
Moreover, omPKA expression resulted in a robust relocalization
of Drp1 towards mitochondria (43%, Figure 5E,F). Together,
these data implicate Drp1 as a target of PKA/AKAP1 and suggest
that phosphorylation may slow the catalytic cycle of Drp1 by
trapping the fission protein at the mitochondrial membrane.
Drp1 SerPKA Phosphorylation Is Required for PKA/AKAP1-
Mediated Mitochondrial Fusion
To explore the role of Drp1 phosphorylation in mitochondrial
remodeling by PKA, we replaced endogenous Drp1 in PC12 cells
with mutant Drp1 that cannot be phosphorylated by PKA
(SerPKAAla, SerPKA= Ser656 in rat splice variant 1) and analyzed
Mechanism of Mitochondrial Fusion by PKA/AKAP1
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lated cAMP levels. Mutation of SerPKA in Drp1 rendered cells
largely refractory to mitochondrial elongation by cAMP
(Figure 6A,B). To confirm the critical importance of Drp1 SerPKA
in the mitochondria-shaping effects of PKA in non-neuronal cells,
HeLa cells expressing either wild-type or SPKAA-mutant Drp1
were also transfected with the catalytic subunit of PKA, either with
or without an OMM targeting sequence. Compared to control
transfected cells, both forms of PKA resulted in significant
mitochondrial elongation, with mitochondrial PKA being more
effective than cytosolic PKA. The non-phosphorylatable Drp1
mutant attenuated mitochondrial remodeling by either form of
PKA to a similar extent (Figure 6C,D).
We then explored the role of basal PKA activity in the
maintenance of mitochondrial shape. Incubation of HeLa cells
with the PKA inhibitor H89 resulted in a protracted loss of
phosphate from Drp1 SerPKA but did not affect Drp1 phosphor-
ylation at the neighboring SerCDK (Figure 6E). Paralleling the time
course of Drp1 SerPKA dephosphorylation, mitochondria in wild-
type GFP-Drp1-expressing cells underwent fragmentation upon
endogenous PKA inhibition. HeLa cells expressing pseudopho-
sphorylated Drp1 (SerPKAAsp mutant) on the other hand were
completely refractory to H89-induced mitochondrial fission
(Figure 6F,G).
To examine the influence of AKAP1 on Drp1 phosphorylation,
COS cells were co-transfected with Drp1 and either empty vector,
wild-type AKAP1, or the PKA-binding deficient AKAP1 mutant
and stimulated with forskolin/rolipram. Especially at lower
forskolin/rolipram concentrations, recruitment of the PKA
holoenzyme to mitochondria via wild-type AKAP1 significantly
enhanced Drp1 phosphorylation at SerPKA (Figure 7A,B). Essen-
tially identical results were obtained with neuronal PC12 cells
(Figure S7). Rationalizing these findings, we hypothesize that
SerPKA of mitochondrial Drp1 is more exposed to phosphorylation
by PKA; alternatively, SerPKA-phosphorylated, mitochondrial
Drp1 may be relatively protected from cytosolic protein
phosphatases, such as calcineurin.
Next, we investigated the role of Drp1 phosphorylation in
AKAP1-mediated mitochondrial fusion. For this set of experi-
ments, HeLa cells expressing empty vector, wild-type, or PKA
binding-deficient AKAP1 in addition to wild-type or SPKAA-
mutant Drp1 were treated with forskolin/rolipram to activate
PKA. As in neuronal cells, AKAP1 promoted mitochondrial
network formation that depended on recruitment of PKA.
Furthermore, PKA/AKAP1-induced mitochondrial elongation
was nearly abolished when endogenous Drp1 was replaced with
the SerRAla mutant (Figure 7C,D).
We confirmed an epistatic relationship between AKAP1 and
Drp1 SerPKA in primary hippocampal neurons. Substitution of
endogenous with SerRAla-mutant Drp1 resulted in mitochondrial
fragmentation, whereas the SerRAsp mutant caused mitochon-
drial elongation as assessed in dendrites (form factor: Figure S8B;
length: Figure S8C). Co-expression of wild-type AKAP1 length-
ened dendritic mitochondria in wild-type GFP-Drp1 substituted
neurons, but not in neurons expressing either SerPKA mutant.
Figure 4. Mitochondrial restructuring underlies survival regu-
lation by outer mitochondrial PKA. (A, B) Hippocampal neurons
were transfected with the indicated plasmid combinations and scored
after 2–3 d for mitochondrial morphology (A, live TMRM stain) or after
5–6 d for apoptosis (B, % transfected neurons with condensed/
fragmented nuclei). Means 6 s.e.m. of n=3–6 experiments are shown.
(C) Model summarizing effects of PKA/AKAP1 on mitochondrial shape
and neuronal survival.
doi:10.1371/journal.pbio.1000612.g004
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S8). These experiments indicate that PKA/AKAP1 inhibits
mitochondrial fission by phosphorylating Drp1 at SerPKA.
AKAP1 has previously been reported to promote phosphory-
lation of the proapoptotic Bcl2 family member Bad in PC12 cells,
and Bad phosphorylation and cytosolic sequestration was
proposed to underlie the neuroprotective effect of PKA/AKAP1
[24]. To examine whether Drp1 may instead be the critical
prosurvival substrate of PKA/AKAP1, we challenged transiently
transfected PC12 cells with the classical apoptosis inducer
staurosporine, a broad-spectrum kinase inhibitor previously shown
to dephosphorylate Drp1 at SerPKA [18]. Compared to AKAP1
DPKA or scrambled shRNA, overexpression of wild-type AKAP1
significantly attenuated apoptosis induced by staurosporine
(0.5 mM for 24 h) when endogenous Drp1 was replaced with
wild-type GFP-Drp1. Replacement with SerRAla mutant Drp1,
instead, negated the antiapoptotic effect of AKAP1 (Figure 7E,F).
Conversely, AKAP1 knockdown in wild-type GFP-Drp1 express-
ing cells moderately increased the percentage with apoptotic nuclei
compared to scrambled shRNA. Pseudophosphorylated (SRD
mutant) Drp1 overcame the proapoptotic effect of AKAP1
shRNA, reducing staurosporine-induced apoptosis to levels
comparable to AKAP1 overexpression (Figure 7E,F). These results
provide strong evidence that AKAP1 acts through Drp1 (and not
Bad) to inhibit the intrinsic apoptosis cascade in PC12 cells.
SerPKA Phosphorylation by PKA/AKAP1 Assembles Drp1
Into Large, Slowly Recycling Mitochondrial Complexes
FRAP and subcellular fractionation experiments so far suggest
that AKAP1 recruits PKA to phosphorylate Drp1 at the OMM,
which inhibits the membrane scission activity of Drp1 by trapping
the protein in slow-turnover complexes (Figure 5). We returned to
FRAP experiments in HeLa cells to establish a requirement for
PKA binding to AKAP1 and SerPKA phosphorylation of Drp1 in
this process. Compared to AKAP1DPKA, co-expression of wild-
type AKAP1 significantly slowed fluorescence recovery of
mitochondrial GFP-Drp1 (.3-fold increase in t1/2; Figure 8A–
C, Video S1). Furthermore, as seen in forskolin/rolipram-
stimulated PC12 cells, wild-type AKAP1 expression resulted in a
shift of GFP-Drp1 localization from cytosol to mitochondria
(Figure 8A). In striking contrast, PKA site-mutant (SPKAA) GFP-
Drp1 was completely insensitive to PKA/AKAP1 recruitment,
displaying rapid recovery comparable to wild-type Drp1 cotrans-
fected with AKAP1DPKA (Figure 8A,C).
Cytosolic Drp1 is a tetramer, which upon translocation to the
OMM is thought to oligomerize into spiral or ring-shaped
superstructures. In analogy to dynamin, GTP hydrolysis may
trigger disassembly of Drp1 oligomers and concomitant mem-
brane fission [28]. In order to provide evidence that outer
mitochondrial PKA promotes SerPKA-dependent oligomerization
of Drp1, we performed crosslinking experiments with dithiobis-
maleimidoethane (DTME), a membrane-permeant, reversible,
and Cys-reactive crosslinker. Transfected COS cells were cross-
linked in vivo, and cell lysates were subjected to ultracentrifugation
(300,000 x g) to assess Drp1 assembly into large, sedimentable
complexes. Compared to co-expression of OMM-targeted GFP,
OMM-targeted PKA enhanced oligomerization of wild-type but
not SerPKA-mutant Drp1 (Figure 8D), providing a biochemical
correlate for the slowly recycling, mitochondrial Drp1 pool we
observed in our FRAP experiments.
GTPase-Impairment Phenocopies Phosphorylation of
Drp1
How does PKA/AKAP1-mediated phosphorylation stabilize
Drp1 oligomers at the OMM? SerPKA phosphorylation was
previously shown to inhibit intrinsic GTP hydrolysis by Drp1 [19].
Dnm1, the yeast ortholog of Drp1, assembles into fission-
competent complexes in its GTP-bound state, but assembly also
stimulates GTP hydrolysis, effectively limiting the size of Dnm1
oligomers at the OMM [28]. Therefore, an attractively simple
hypothesis compatible with our observations is that PKA/AKAP1
phosphorylation of Drp1 attenuates GTP hydrolysis, thereby
allowing Drp1 oligomers to grow beyond a size that is compatible
with membrane remodeling.
This hypothesis predicts that GTPase-impaired Drp1 mutants
should behave similarly to phospho-SerPKA Drp1. We initially
analyzed the widely used dominant-negative K38A mutant of
Drp1, which affects a critical Lys residue in the nucleotide binding
fold. However, Drp1 K38A was found to localize exclusively in
large spherical aggregates that only occasionally overlapped with
mitochondria and that did not exchange with one another as
detectable by FRAP analysis (unpublished data). Aiming for a
milder phenotype, we targeted Thr55 in the Drp1 GTPase
domain (Figure 9A) based on a mutagenesis study of the related
dynamin-2. Ser61, the corresponding residue in dynamin-2, lies
within the nucleotide binding pocket but does not directly
coordinate GTP [29]. Mutation of Ser61 to Asp was shown to
significantly lower the maximal rate of GTP hydrolysis (Kcat)
without affecting the Km or apparent affinity of dynamin-2 for
GTP [30].
To assess the effect of the T55D mutation on mitochondrial
morphology, HeLa cells were transfected with different ratios of
wild-type and T55D-mutant GFP-Drp1 plasmid (replacing
endogenous Drp1 by RNAi from the same plasmid). Drp1
T55D expression resulted in a dose-dependent increase in
mitochondrial length, demonstrating that the mutation impairs
Drp1’s fission activity (Figure 9B,C). Remarkably, GFP-Drp1
T55D also displayed a more pronounced, punctate mitochondrial
localization than wild-type Drp1 (Figure 9B). Quantitative analysis
confirmed that GFP-Drp1 colocalization with mitochondria
(Manders’ coefficient) was positively correlated with relative
expression levels of Drp1 T55D, as well as with mitochondrial
Figure 5. cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. (A) Confocal micrograph showing
mixed cytosolic and mitochondrial localization of GFP-Drp1 in PC12 cells (mito, MitoTracker Deep Red). (B–D) FRAP analysis in PC12 cells shows
opposite effects of PKA activation and AKAP1 knockdown on GFP-Drp1 dynamics. PC12 cells co-expressing GFP-Drp1 and either AKAP1-directed or
control shRNA were treated 6 forskolin/rolipram (25/1 mM, 1–3 h) and Drp1 turnover was measured by bleaching mitochondrial GFP-Drp1 in a
565 mm square and monitoring fluorescence recovery at 5 s intervals. (B) shows frames from representative cells (control, forsk/roli: control shRNA 6
forskolin/rolipram; shAKAP1: AKAP1 shRNA #1), (C) shows averaged fluorescence recovery curves, and (D) plots Drp1 turnover as the ratio of mobile
fraction (mFx) and 50% recovery time (t1/2) derived from biexponential fits (R
2,0.99) of individual recovery curves (means 6 s.e.m. of 8–10 cells for
each condition from a representative experiment). (E–F) Subcellular fractionation of Drp1. COS cells co-expressing GFP-Drp1 with either outer
mitochondrial (om) PKA (+) or omGFP (2) were permeabilized with digitonin (500 mg/ml) and fractionated into a cytosolic (cyto) and a heavy
membrane fraction containing mitochondria (mito). Fractions were immunoblotted for total Drp1, phospho-SerPKA Drp1 (pDrp1), and the
mitochondrial marker TOM40 and analyzed by densitometry (E, representative blot; F, summary showing means 6 s.e.m. of 6 independent
experiments).
doi:10.1371/journal.pbio.1000612.g005
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PLoS Biology | www.plosbiology.org 8 April 2011 | Volume 9 | Issue 4 | e1000612Figure 6. PKA shapes mitochondria through phosphorylation of Drp1 at SerPKA. (A, B) PC12 cells expressing mitochondrial GFP (green) and
either wild-type or SPKAA-mutant Drp1 instead of endogenous Drp1 were treated 6 forskolin/rolipram (25/2 mM, 3 h), fixed, and epifluorescence
micrographs (representatives in A) were subjected to digital morphometry (means 6 s.e.m. of ,300 cells per condition from a representative
experiment). (C–D) HeLa cells co-expressing the indicated constructs (om, outer mitochondrial) were fixed and processed for immunofluorescence for
mitochondrial cytochrome oxidase II (mito, red) and GFP (green). Shown are representative images (C) and mitochondrial morphology analysis (D,
means 6 s.e.m. of ,200–300 cells per condition from a representative experiment). (E–G) HeLa cells expressing WT or SPKAD-mutant GFP-Drp1 were
incubated for up to 4 h with the PKA inhibitor H89 (20 mM) and analyzed by quantitative immunoblotting for phosphorylated (pDrp1, SerPKA, and
SerCDK) and total Drp1 (E) or by immunofluorescence for mitochondrial morphology (F, representative image; G, means 6 s.e.m. of ,200 cells/
condition from a representative experiment). For immunoblot analysis only (E), trace amounts (5% plasmid) of PKA catalytic subunit were
cotransfected to increase the signal strength with the phospho-SerPKA Drp1 antibody.
doi:10.1371/journal.pbio.1000612.g006
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PLoS Biology | www.plosbiology.org 9 April 2011 | Volume 9 | Issue 4 | e1000612Figure 7. AKAP1 promotes mitochondrial elongation and neuronal survival by enhancing phosphorylation of Drp1 at SerPKA. (A, B)
COS cells co-expressing GFP-Drp1 and either empty vector, wild-type, or DPKA-mutant GFP-AKAP11–524 were stimulated for 45 min with increasing
concentrations of forskolin/rolipram (rolipram at 1/30
th of the indicated forskolin concentrations), and total cell lysates were probed for phospho-
SerPKA Drp1 and GFP (detecting Drp1 and AKAP1) on the same blot using a dual-channel infrared imager. Drp1 phosphorylation was quantified as the
ratio of phospho- to total Drp1 signals normalized to the highest value and is shown as part of the representative blots (A) and the summary graph
(B, means 6 s.e.m. of 6 independent experiments). (C, D) HeLa cells co-expressing the indicated constructs (DPKA = I310P, L316P-mutant) were
treated with forskolin/rolipram (25/2 mM, 3 h) and processed for immunofluorescence for mitochondrial cytochrome oxidase II (mito, red) and V5-
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T55D substitution dramatically attenuates mitochondrial Drp1
dynamics, again in a dose-dependent manner, slowing turnover by
up to 10-fold (Figure 9D,E; Video S2). Similar to phosphorylation
at SerPKA, the T55D mutation also increased the propensity of
Drp1 to form sedimentable oligomeric structures after intact cell
crosslinking (Figure 9F).
Therefore, inhibition of GTP hydrolysis (either by mutation of
the GTPase domain or by phosphorylation of SerPKA by PKA/
AKAP1) leads to a stable accumulation of Drp1 at mitochondria,
likely by interfering with a disassembly step that is required for
mitochondrial fission.
PKA Phosphorylation and T55D Substitution Extend the
Lifetime of Mitochondrial Drp1 Foci
In an effort to provide direct evidence that PKA phosphory-
lation slows the turnover of mitochondrial Drp1 complexes, we
imaged HeLa cells expressing GFP-Drp1 and mitochondrial
dsRed2 at high magnification (6306). Wild-type GFP-Drp1 foci
were mostly found to abut mitochondria, seemingly randomly
translocating along their length and pivoting around the organelle
(Figure 10A, Video S3). Mitochondrial fission events were
observed only at sites of GFP-Drp1 accumulation, and GFP-
Drp1 punctae frequently divided to segregate with the new
mitochondrial ends. When PKA was co-expressed, GFP-Drp1
punctae appeared larger and less dynamic, and the frequency of
mitochondrial fragmentation events decreased. Foci formed by
GTPase-impaired, T55D mutant Drp1 displayed a similar albeit
even more accentuated behavior, which correlated with the near
absence of fission events during the 1 h recording period
(Figure 10A, Video S3).
Movies were subjected to automated particle tracking analysis
[31], extracting average lifetimes of mitochondria-associated GFP-
Drp1 punctae at 37uC. Wild-type Drp1 punctae could be tracked
for an average of 3.5 min, whereas co-expression of PKA or the
T55D mutation increased the persistence of GFP-Drp1 punctae to
5.4 and 6.7 min, respectively (Figure 10B).
Discussion
This report establishes a role for outer mitochondrial PKA and,
in particular, the PKA/AKAP1 complex in the maintenance of
mitochondrial integrity and the protection from neuronal injury.
The importance of cAMP/PKA signaling in cell survival is well
documented [26]. Phosphorylation and inactivation of Bad, a pro-
apoptotic Bcl2-family protein, has been put forward as one of the
critical survival promoting substrates of mitochondria-localized
PKA [32,33]. While AKAP1 expression in PC12 cells was shown
to increase Bad phosphorylation at multiple sites [24], our results
indicate that Bad phosphorylation does not significantly contribute
to the anti-apoptotic function of AKAP1. Instead, we present
evidence that PKA targeting via AKAP1 opposes cell death mainly
by gating Drp1-dependent mitochondrial fission. Specifically,
inhibition of endogenous PKA via OMM-targeted PKI leads to
mitochondrial fragmentation and sensitizes neurons to pro-
apoptotic stimuli, both of which are reversed by blocking the
mitochondrial fission machinery. Conversely, recruiting PKA to
mitochondria via expression of AKAP1 resulted in mitochondrial
elongation in cell culture and in vivo and protected hippocampal
neurons from rotenone toxicity. Both mitochondrial elongation
and survival enhancement by AKAP1 required PKA anchoring
and SerPKA-phosphorylatable Drp1, indicating a critical role for
the PKA-Drp1 axis.
However, our results do not rule out the possibility that PKA
may cause mitochondrial elongation by promoting mitochondrial
fusion events in addition to inhibiting mitochondrial division. For
instance, a recent report showed that forskolin can stimulate
mitochondrial fusion in a cell-free assay [34].
AKAP1 is a large, multifunctional adaptor protein with several
splice variants and a highly conserved N-terminal transmembrane
domain that acts as a mitochondrial targeting sequence [35].
Besides localizing the PKA holoenzyme, AKAP1 also interacts
with the tyrosine phosphatase PTPD1, and through PTPD1 with
the tyrosine kinase Src, as well as two Ser/Thr phosphatases, PP1
and PP2B [36–38]. The C-terminus of AKAP1 contains Tudor
and KH RNA binding domains, which were suggested to localize
nucleus-derived mRNAs encoding mitochondrial proteins close to
their destination [39].
A recent study described nuclear aggregation of mitochondria
upon overexpressing an N-terminal fragment of AKAP1 contain-
ing the PKA binding domain. The authors did not, however,
investigate whether this effect was PKA dependent and instead
attributed the phenotype to a lack of RNA binding to the missing
C terminus [37]. In the present study, we consistently observed
elongation but rarely nuclear aggregation of mitochondria,
regardless of whether full-length or C-terminally truncated
AKAP1 (residues 1–524) was expressed. High levels of AKAP1
overexpression did sometimes induce nuclear aggregation of
mitochondria, which may therefore be secondary to exaggerated
fusion of the organelle. Mitochondrial remodeling depended on an
intact PKA binding domain and was phenocopied and reversed by
direct OMM tethering of PKA and PKI, respectively. Thus, PKA
targeting is both necessary and sufficient for AKAP1-dependent
regulation of mitochondrial morphogenesis.
Both the PKA and the PTPD1/Src interaction domains are
important for maintenance of mitochondrial membrane potential
by AKAP1 [40]. Hence, either mitochondrial recruitment of
PTPD1/Src or an as yet undefined structural role of AKAP1 may
explain why mitochondrial fission inhibitors rescue hippocampal
neurons from omPKI expression but not from AKAP1 knock-
down.
Consistent with an essential role for AKAP1 in neuronal
survival, a recent report demonstrated that ischemia induces
expression of the E3 ubiquitin ligase Seven In-Absentia Homolog
2 (Siah2), which targets AKAP1 for rapid proteasomal degradation
[41]. Our study predicts that the hypoxia-induced loss of PKA
anchoring at the OMM leads to disinhibition of Drp1 and
contributes to the massive mitochondrial fragmentation that is a
hallmark of ischemic brain injury [42].
We have identified a conserved PKA phosphorylation site in the
GTPase effector domain of Drp1 as the principal mediator of
PKA/AKAP1-induced mitochondrial remodeling. AKAP1-medi-
tagged AKAP1 (green). Shown are representative images (C) and mitochondrial morphology analysis (D, mean 6 s.e.m. of ,200–300 cells per
condition from a representative experiment). (E, F) PC12 cells were cotransfected with GFP-Drp1/shRNA expression plasmids and either AKAP1 cDNAs
or shRNAs. Cultures were treated 48 h posttransfection with 0.5 mM staurosporine for 24 h, fixed, and stained with Hoechst 33342. Representative
images in (E) show overlays of cell contours (bright field), GFP-Drp1 (green), and Hoechst-stained nuclei (blue), with transfected cells displaying
normal nuclear morphology and many untransfected cells having condensed, apoptotic nuclei (arrows). Apoptosis was quantified as the percentage
of GFP-positive cells with condensed or fragmented nuclei (E, means 6 s.e.m. of 6–13 image fields with ,300 transfected cells per condition from
one experiment representative of three).
doi:10.1371/journal.pbio.1000612.g007
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phosphorylation, and mitochondria of cells expressing SerPKAAla-
substituted Drp1 were unresponsive to cAMP and PKA/AKAP1.
As to a mechanism, Drp1 activation via AKAP1 silencing was
associated with accelerated cycling of the fission enzyme between
cytosolic and mitochondrial pools. Conversely, Drp1 inhibition via
cAMP or PKA recruitment or overexpression resulted in the
accumulation of stable Drp1 oligomers at mitochondria and in an
extension of the lifetime of mitochondrial Drp1 foci. Because
SerPKA phosphorylation decreased the Kcat of GTP hydrolysis and
because a mutation that stabilizes the GTP bound form of Drp1
mimicked the effects of PKA phosphorylation on localization and
dynamics of the fission enzyme, modulation of Drp1’s GTP cycle
emerges as a probable mechanism for the mitochondria-stabilizing
and neuroprotective actions of PKA/AKAP1.
A previous FRAP study demonstrated that the apoptosis
inducer staurosporine causes accumulation of slowly recycling
mitochondrial YFP-Drp1 complexes, which colocalize with Bax
and Bak. Since the arrest of Drp1 cycling occurs after
mitochondria have fragmented but before they release cytochrome
C, this phenomenon may be related to the proapoptotic christae
remodeling activity of Drp1 [43]. Given that the pan-kinase
inhibitor staurosporine actually inhibits Drp1 phosphorylation at
SerPKA [18], mitochondrial accumulation of Drp1 during
apoptosis likely occurs by a mechanism distinct from the one
reported here, such as Drp1 sumoylation ([43,44], but see [45]).
Seemingly at odds with our findings, another study previously
suggested that calcineurin-mediated dephosphorylation of Drp1 at
SerPKA promotes translocation of the fission enzyme to mitochon-
dria, a conclusion largely based on overexpression of phosphor-
ylation site-mutant Drp1 [17]. Confirming and extending the
findings of that report, we found that pseudophosphorylated
(SPKAD-mutant) GFP-Drp1 partitions mostly with the cytosolic
fraction (.90%), oligomerizes less readily than wild-type Drp1,
and only infrequently forms mitochondrial punctae (unpublished
data), which is essentially opposite to the phenotype of Drp1
phosphorylated by PKA. Because Asp substitution of Drp1 SerPKA
at most incompletely reproduces the inhibitory effect of SerPKA
phosphorylation on in vitro GTP hydrolysis [17–19], we propose
that the supposedly phosphomimetic substitution of SerPKA with
an acidic residue locks Drp1 into a partially inhibited state,
arresting the enzyme at a different stage of its subcellular
translocation cycle.
Enhanced colocalization or cofractionation of Drp1 with
mitochondria has previously been interpreted as evidence for
Drp1 activation (e.g. [17,20,46]). Our data and those of Zunino et
al. [44] argue that Drp1 regulation is more complex, in that
mitochondria-associated pools of Drp1 may sometimes be inactive.
Similar considerations apply to higher order oligomeric assembly
of Drp1, which is clearly required for its function as a
mechanoenzyme [28]. The crosslinking and particle tracking data
presented here indicate that excessive oligomerization of Drp1 into
particles unable to constrict and sever mitochondria occurs as a
consequence of SerPKA phosphorylation or mutation of the
GTPase domain.
In support of a model in which PKA/AKAP1 fuses mitochon-
dria by accumulating Drp1 in inactive superstructures
(Figure 10C), recent studies on the mechanism of action of
dynamin suggest that the endocytosis motor assembles into
relatively short oligomers (3 to 4 rungs of a spiral) before GTP
hydrolysis-driven disassembly leads to membrane destabilization
and scission. In contrast, disassembly of larger dynamin oligomers
(assembled in the absence of GTP) does not effectively mediate
membrane scission [47,48].
Outer mitochondrial PKA-induced super-oligomerization of
Drp1 could inhibit cell death by several, non-mutually exclusive
mechanisms. For instance, mitochondrial networks resulting from
unopposed fusion can sustain higher metabolic activity [49], are
relatively resistant to Bax insertion and cytochrome C release [50],
and may also be more effective at sequestering cytotoxic calcium
and reactive oxygen species [51,52]. More directly, PKA-mediated
depletion of the cytosolic Drp1 pool could potentially interfere
with pathological Drp1 activation by sumoylation [43] and
nitrosylation [15] and compete with Drp1 recruitment into Bax/
Bak positive foci during apoptosis [53]. The interplay between
multi-site phosphorylation and other posttranslational modifica-
tions of Drp1 in the regulation of mitochondrial homeostasis and
cell death is undoubtedly complex and will require further
attention.
Materials and Methods
Antibodies
The following antibodies were used: rabbit anti-GFP (ab290,
Abcam), mouse IgG1 anti-MTCO2 (cytochrome oxidase subunit
II, Neomarkers), rabbit anti-ERK (Santa Cruz), mouse anti-
phospho-SerPKA Drp1 [22], rabbit anti-phospho-SerCDK Drp1
(Ser616, Cell Signaling), rabbit anti-LacZ and mouse IgG2a anti-
V5 epitope tag (Invitrogen), mouse anti-neurofilament (2H3,
Developmental Studies Hybridoma Bank, Iowa City), and mouse
anti-MAP2B (BD Transduction Laboratories). For immunofluo-
rescence staining, Alexa fluorophore-coupled secondary antibodies
were purchased from Invitrogen. Infrared fluorophore-coupled
secondary antibodies for quantitative immunoblot analysis were
purchased from LI-COR Biosciences (Lincoln, NE).
cDNA and shRNA Vectors
The core domain of rat AKAP1 that is present in all published
splice variants (residues 1–524) was isolated by reverse transcrip-
tase PCR and fused to the N terminus of EGFP. The PKA-binding
deficient mutant I310P, L316P was generated by mutagenesis
according to the QuikChange protocol (Stratagene). N-terminally
GFP tagged PKA, PKI [54], and PfARP32–239 [55] were modified
by the addition of N-terminal OMM targeting sequences:
hexokinase I1–30 for PKA and MAS70p1–29 for PKI. For the
V5-tagged AKAP1 constructs, the AKAP1 cDNA was excised
from the GFP constructs with BglII and SalI and ligated into the
pcDNA3.1HisV5 vector digested with BamHI and XhoI. AKAP1
and Fis1 were silenced by H1-promoter-driven expression of
shRNAs [56] (pSUPER plasmid [57] or lentivirus [58]). 19 b
Figure 8. PKA/AKAP1 recruits Drp1 into large, slow turnover complexes by phosphorylating SerPKA. (A–C) HeLa cells co-expressing wild-
type or SPKAA-mutant GFP-Drp1 and either wild-type or PKA-binding deficient (DPKA) AKAP1 were subjected to FRAP analysis. (A) Frames showing
time lapse series of representative cells (green: GFP-Drp1, red: MitoTracker Deep Red) with enlargements of the 180 s frame demonstrating recovery
of Drp1 into mitochondrial foci (arrows). (B) Average recovery curves of cells expressing wild-type GFP-Drp1 and either wild-type or mutant AKAP1,
and (C) plots mitochondrial Drp1 turnover as the 50% recovery time calculated from biexponential fits of individual recovery curves (R
2,0.992; means
6 s.e.m. of 5–9 cells each from a representative experiment). (D) COS cells cotransfected with Drp1 and either omGFP or omPKA were treated for
5 min with the indicated concentration of the reversible, membrane permeant crosslinker dithiobismaleimidoethane (DTME), and cleared cell lysates
were subjected to ultracentrifugation to sediment Drp1 complexes.
doi:10.1371/journal.pbio.1000612.g008
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start site in rat mRNAs): AKAP1/#1: 780–788, AKAP1/#4:
740–758, Fis1/#3: 315–333, Fis1/#4: 421–439. The nonspecific
control shRNA had a similar base composition but was
randomized for no more than 14 consecutive matches to any
mammalian mRNA. The Fis1 and control shRNAs were described
previously [21]. Drp1 expression plasmids encoded rat splice
variant 1 with an N-terminal EGFP tag under CMV promoter
control, as well as Drp1-directed shRNA driven by the H1
promoter [18]. GFP-Drp1 was rendered RNAi resistant and
coding mutations were incorporated by site-directed mutagenesis
[18]. All Drp1 transfection experiments in this article involved
concomitant silencing of the endogenous protein.
Western Blot and Immunoprecipitation
For analysis of Drp1 phosphorylation, COS cells were
cotransfected with GFP-tagged AKAP1 and Drp1 at 2:3 plasmid
mass ratios using Lipofectamine 2000. After 24 h, cells were
stimulated with various concentrations of forskolin/rolipram for
45 min, lysed in SDS sample buffer containing 2 mM EDTA
and 1 mM microcystin, and sonicated with a probe tip to shear
DNA. For AKAP1 immunoprecipitation, PC12 cells were
transfected with AKAP1 WT- or AKAP1DPKA-GFP. After
48 h, AKAP1 was immunoprecipitated with GFP antibodies and
protein A-agarose beads essentially as described [59]. Protein
samples were resolved on 8% or 10% polyacrylamide gels and
transferred to nitrocellulose membrane, followed by antibody
detection using a LI-COR Odyssey infrared fluorescence
scanner. Band intensities were quantified using the ImageJ gel
analysis macro set, normalizing to loading controls in the same
lane.
Intact Cell Crosslinking
COS cells were transfected with triple HA-tagged Drp1 and
either omGFP or omPKA expressing plasmids at 3:1 mass ratio
and cultured for 24 h. After a wash with PBS, cells were incubated
Figure 9. A GTPase-compromised Drp1 mutant accumulates in slowly recycling complexes at mitochondria. (A) Drp1 domain diagram.
(B–C) Endogenous Drp1 in HeLa cells was replaced by transfection of the indicated ratios of wild-type (WT) and T55D mutant GFP-Drp1 expression
plasmids. Cells were fixed and analyzed for mitochondrial length and Drp1 colocalization with mitochondria using ImageJ software [22,61]. (B)
Representative images showing punctate localization of GFP-Drp1 T55D (green) on mitochondria (cytochrome oxidase subunit II antibody). (C)
Correlation between mitochondrial length and mitochondrial localization of Drp1 as a function of Drp1 T55D expression (means 6 s.e.m. of ,200
cells per condition from a representative experiment). Wild-type and T55D-mutant Drp1 expression levels are similar and scale with plasmid amounts
(inset). (D, E) Turnover of GFP-Drp1 WT and T55D was analyzed by FRAP as in Figure 8. (D) Frames showing representative time lapse series (green:
GFP-Drp1, red: MitoTracker Deep Red, see Video S2) of HeLa cells expressing 100% WT or T55D Drp1, with the last frame expanded to show recovery
of WT Drp1 into mitochondrial foci (arrows). (E) Average recovery curves (left) and curve fit-derived turnover (right, ratio of mobile fraction [mFx] and
50% recovery time [t1/2]) from cells expressing varying ratios of WT and T55D-mutant GFP-Drp1 (mean 6 s.e.m. of 12–20 cells each from a
representative experiment). (F) COS cells expressing GFP-Drp1 WT or T55D were incubated with DTME (5 min, 500 mM), and cleared cell lysates were
subjected to ultracentrifugation to sediment Drp1 complexes (,2-fold increase with the T55D mutation).
doi:10.1371/journal.pbio.1000612.g009
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(DTME, from freshly prepared 506stocks in DMSO) for 5 min at
37uC. The HBSS/DTME was removed and cells were lysed in
buffer containing 60 mM Tris pH 6.8 and 2% SDS. Insoluble
debris was removed by centrifugation (10 min at 14,000 x g) and
cleared lysates (300 ml) were layered onto 1 ml of a 300 mM
sucrose cushion and subjected to ultracentrifugation (30 min at
300,000 x g). Pellets were dissolved in SDS sample buffer
containing 5% b-mercaptoethanol to cleave the crosslinker and
analyzed by SDS-PAGE alongside an aliquot of the lysate prior to
ultracentrifugation.
Neuronal Survival Assays
Hippocampal neurons from E18 rat embryos [60] were cultured
in Neurobasal medium with B27 supplement (Gibco) and
transduced with lentivirus or transfected using LipofectAmine
2000 (0.15%, 2 mg/ml DNA) at 10–21 d in vitro. For survival
assays based on counting transfected neurons or apoptotic nuclei,
GFP- or b-galactosidase-expressing plasmids were cotransfected.
After 3 to 5 d, cultures were challenged with rotenone (400 nM
continuous) and fixed with 3.7% paraformaldehyde and processed
for immunofluorescence staining for the transfection marker
(aGFP and aLacZ) and neurofilament protein as a neuronal
Figure 10. PKA phosphorylation and T55D mutation prolong the lifetime of mitochondrial Drp1 foci. (A, B) HeLa cells transfected with
GFP-Drp1 (green), dsRed2/mito (COX8 matrix targeting sequence, red), 6 PKA catalytic subunit were imaged for $1 h at 37uC, capturing images
every 30 s. (A) Representative frames of time lapse series (see Video S3). Blue lines connect GFP-Drp1 punctae that could be tracked for at least 5 min;
x symbols denote mitochondrial fission events. Note that GFP-Drp1 punctae often split with the fragmenting mitochondrion. (B) Cumulative
frequency plot of Drp1 punctae lifetimes and average lifetimes (bar graph inset; means 6 s.e.m. of 35–62 cells and 11,000 to 40,000 punctae per
condition from two independent experiments). (C) Model of mitochondrial fusion by PKA/AKAP1. GTP-bound Drp1 translocates to mitochondria to
assemble into oligomeric complexes. Drp1 assembly stimulates GTP hydrolysis, leading to mitochondrial fission and release of Drp1 into the cytosol
to complete the cycle. OMM-anchored PKA/AKAP1 phosphorylates Drp1 at SerPKA, stabilizing the GTP-bound state to promote growth of Drp1
complexes to a size that is incompatible with membrane scission. Protein phosphatases (PP), including calcineurin, dephosphorylate Drp1 SerPKA to
return Drp1 into its active, rapidly cycling state.
doi:10.1371/journal.pbio.1000612.g010
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neurons with intact processes were counted in quadruplicate wells
of a 24-well plate. Apoptosis was quantified as the percentage of
transfected neurons with condensed, irregular, or fragmented
nuclei (labeled with 1 mg/ml Hoechst 33342). All survival assays
based on counting neurons were performed blind to the
experimental conditions.
Mitochondrial Morphology Assays in Cell Culture
HeLa cells, PC12 cells, and hippocampal neurons cultured on,
respectively, untreated, collagen-, and poly-D-lysine-coated,
chambered No. 1 cover glasses (20 mm
2 chamber, Nalge Nunc)
were infected with lentivirus or transfected using LipofectAmine
2000 as above. Hippocampal cultures were infected or transfected
at 8 to 10 d in vitro and analyzed 3 to 5 d later. For live cell
imaging 24 to 96 h post-transfection, cells were incubated with
100 nM TMRM for 30 min at 37uC to visualize mitochondria,
and images through the midplane of the soma were captured using
a Zeiss LSM 510 laser-scanning confocal microscope. For analysis
of fixed cells, cultures were subjected to immunofluorescence
staining with antibodies to cytochrome oxidase II (HeLa cells only)
and GFP [22], and images were captured with a Leica
epifluorescence microscope.
Mitochondrial morphology was scored by reference image-
based and software-based methods. For the former, coded images
were assigned scores from 0 to 4 by comparison to a set of
reference images with increasing degrees of mitochondrial
elongation and clustering (Figure S1A). For automated morphom-
etry, images were processed using ImageJ software and plugins,
involving either ‘‘rolling ball’’ background subtraction or deblur-
ring by 2-D deconvolution with a computed point spread function.
Using a custom-written ImageJ macro, processed images were
converted to binary (black and white) images by auto-thresholding,
and mitochondrial particles were analyzed for length, width, area
(a), and perimeter (p) [22]. Metrics that reliably reported the effects
of manipulating components of the mitochondrial fission/fusion
machinery (e.g. wild-type or dominant-negative Drp1 expression,
Fis1 or Drp1 RNAi) included form factor (p
2/(4p*a)) and
cumulative area:perimeter ratio (Sa/Sp). The form factor is
reported as an average of all particles in a region-of-interest (ROI),
has a minimum value of 1 (for perfect circles), and captures well
the transition from punctiform to elongated, complex shaped, but
still isolated mitochondria. The cumulative area:perimeter ratio is
computed as the summed particle area in a ROI divided by the
summed particle perimeter (including the perimeter of enclosed
spaces or ‘‘holes’’). This metric is particularly effective at detecting
the transition from elongated, isolated mitochondria to a reticular
network of interconnected mitochondria. Colocalization of GFP-
Drp1 with mitochondria (Figure 9C) was quantified as the
Manders’ coefficient using the JaCoP plug-in for ImageJ [61].
In Vivo Mitochondrial Morphology Analysis
All animal procedures were approved and carried out according
to the Institutional Animal Care and Use Committee (IACUC) at
the University of Iowa. Adult male Lewis rats were anesthetized
with 91/9.1 mg/kg of ketamine/xylazine and placed in a
stereotaxic apparatus. Concentrated stocks (,10
8 particles/ml)
of lentivirus (feline immunodeficiency virus), prepared by the
University of Iowa Viral Vector Core, were bilaterally injected
into the striatum and hippocampus using a 10 ml Hamilton syringe
with a 30u beveled 30 gauge needle. Virus expressing mitochon-
dria-targeted GFP (via residues 1–31 of cytochrome oxidase
subunit VIII) and AKAP1-GFP were delivered into the left and
right hemisphere, respectively. The following coordinates were
used with the incisor bar at 3.3 (from bregma): Striatum, AP=0,
ML=63.5, DV=24.5; Hippocampus, AP=24.0, ML=62.0,
DV=23.5. Animals were sacrificed 7–14 d later and transcar-
dially perfused with 4% paraformaldehyde. 40 mm thick coronal
cryostat sections were processed for indirect immunofluorescence
with antibodies to GFP and MAP2B and counterstained for nuclei
with TOPRO-3. Ten to 22 confocal z-sections of infected neurons,
0.8 mm apart, were captured and analyzed for mitochondrial
shape by digital morphometry as described above.
Fluorescence Recovery after Photobleaching
Hela and PC12 cells were grown on collagen-coated, cham-
bered No. 1 cover glasses (Nunc, Thermo Fisher), transfected 24
to 48 h, and stained with MitoTracker Deep Red 30 min prior to
analysis. Cells with non-mitochondrial GFP-Drp1 aggregates, a
sign of overexpression, were excluded from the analysis. Using the
488 nm laser line of a Zeiss LSM 510 confocal microscope, an
approx. 565 mm region of mitochondria-associated GFP-Drp1
was bleached and fluorescence recovery was tracked by capturing
images every 5 s for 5 min. Image stacks were analyzed, and
recovery curves normalized to pre-bleach intensity and corrected
for acquisition bleach [27] were approximated by single and
double exponential recovery equations using a custom-written
ImageJ macro, yielding 50% recovery time constant (t1/2) and
mobile fraction (mFx). Drp1 dynamics followed double exponen-
tial recovery kinetics with R
2 values of generally greater than 0.99.
Control experiments, in which bleach recovery of cytosolic and
mitochondrial Drp1 was tracked separately by masking the GFP
channel with the MitoTracker channel, showed that mitochon-
drial masking does not significantly affect the results (unpublished
data).
GFP-Drp1 Particle Tracking
HeLa cells cotransfected with GFP-Drp1, dsRed2/mito, and
either empty vector or PKA catalytic subunit at 15:4:1 plasmid
ratios were subjected to time lapse imaging using the 636
objective of a motorized Leica AF6000 epifluorescence microscope
under temperature (37uC) and CO2 (5%) control. Frames were
captured at 30 s intervals for 60 to 90 min, contrast-enhanced
(contrast-limited adaptive histogram equalization [CLAHE] plu-
gin for ImageJ), and analyzed with the Particle Tracker plugin for
ImageJ [31]. Text files containing particle trajectories were parsed
with a custom-written macro to obtain mean particle lifetimes and
lifetime histograms.
Subcellular Fractionation
COS cells expressing GFP-Drp1 with or without omPKA were
permeabilized in 0.5 mg/ml digitonin, 100 mM KCl, 20 mM
HEPES pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM benzami-
dine, 5 mg/ml leupeptin, 1 mM dithiotreitol (DTT), and 1 mM
phenylmethylsulfonyl fluoride (PMSF). Cytosolic and heavy
membrane fractions were prepared by centrifugation (10 min,
20,000 x g, 4uC).
Statistical Analysis
Data were analyzed by Student’s t test (two-tailed) for single
comparisons and by one-way analysis of variance (ANOVA)
followed by pairwise Bonferroni post hoc tests for multiple
comparisons.
Supporting Information
Figure S1 Reference image-based and automated methods yield
similar mitochondrial morphology scores. (A) Confocal images of
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as reference images for quantification of mitochondrial morphol-
ogy (increasing length scores from 0 to 4). (B, C) Comparison of
blinded reference image-based length scores (B) and digital
morphometry (C) applied to confocal images of hippocampal
neurons expressing Bb2- or AKAP1-directed or nonsense (NS)
shRNAs (means 6 s.d. of 12–28 neurons). The cumulative
area:perimeter ratio (Sa/Sp) can account for mitochondrial
clusters and achieves significance values approaching that of the
reference-image-based method. (D) Cell-by-cell correlation of
reference-image-based length scores and cumulative area:peri-
meter ratios in neurons expressing Bb1o rB b2 and Bcl2. Small
symbols represent values from individual neurons; the large
symbols are population means (6 s.d.).
Found at: doi:10.1371/journal.pbio.1000612.s001 (0.38 MB TIF)
Figure S2 A point mutation and two shRNAs interfere with
AKAP1 function/expression and Drp1 shRNA permits assembly
of pure GFP-Drp1 oligomers. (A) Wild-type (WT) and mutant
(DPKA = I310P,L316P) AKAP1-GFP were immunoprecipitated
via GFP from transfected COS cells and analyzed for association
with the PKA regulatory subunit RIIa; the asterisk indicates
immunoglobulin heavy chain. (B) Hippocampal cultures were
cotransfected with a 1:1:2 mass ratio of plasmids expressing the
indicated target proteins fused to the N terminus of firefly
luciferase (luc), Renilla luciferase, and shRNAs (NS, nonsense).
Knockdown was assessed 3 d later by dual-luciferase assays.
AKAP1-directed shRNAs were as effective as a positive control
shRNA targeting the luc coding sequence. (C) PC12 cells
transfected with the indicated shRNA plasmids were probed for
endogenous AKAP1 and ERK1/2 expression (duplicate cultures).
At least two AKAP1 splice variants are expressed in PC12 cells,
with the ,120 kD variant predominating. (D) HeLa cells were
transfected with GFP-Drp1 expression plasmids that include (+)o r
exclude (2) a H1 promoter-shRNA cassette to silence endogenous
Drp1, and GFP immunoprecipitates were probed with Drp1
antibodies. Endogenous Drp1 assembles with (RNAi-resistant)
GFP-Drp1 only in the absence of Drp1-directed shRNA.
Found at: doi:10.1371/journal.pbio.1000612.s002 (0.25 MB TIF)
Figure S3 AKAP1 regulates mitochondrial shape in dendrites of
hippocampal neurons. Hippocampal cultures were transfected
with mitochondrial GFP and the indicated constructs at 1:4 mass
ratio at 10 DIV and fixed 3 d later for analysis of mitochondrial
shape in dendrites. (A) Representative epifluorescence images and
graphs (B) showing mitochondrial form factor (mean 6 s.e.m. of
40–50 neurons from a representative experiment). p values refer to
comparisons to control (nonsense shRNA) transfected conditions.
Found at: doi:10.1371/journal.pbio.1000612.s003 (0.26 MB TIF)
Figure S4 Rescue of rat AKAP1 knockdown-induced mito-
chondrial fragmentation by expression of human AKAP1. PC12
cells were cotransfected with mitochondrial GFP, the indicated
shRNAs, and either human AKAP1 cDNA or empty vector, fixed
after 3 d, and analyzed by epifluorescence microscopy. (A)
Representative images (green, mitochondria; blue, DNA) and
graphs (B) depicting mitochondrial shape analysis from a
representative experiment (mean 6 s.e.m. of 300–400 cells per
condition).
Found at: doi:10.1371/journal.pbio.1000612.s004 (1.31 MB TIF)
Figure S5 Neuronal death due to AKAP1 silencing cannot be
rescued by inhibiting mitochondrial fission. Hippocampal cultures
were cotransfected with plasmids expressing AKAP1-directed or
control shRNAs and the indicated rescue plasmids and analyzed
after 5 d for mitochondrial morphology (A) and apoptosis (B)
(means 6 s.e.m. of 3–5 experiments). Bcl2, but neither dominant-
negative Drp1 nor Fis1 RNAi, attenuates apoptosis associated with
AKAP1 knockdown.
Found at: doi:10.1371/journal.pbio.1000612.s005 (0.14 MB TIF)
Figure S6 Protonophore-mediated mitochondrial fragmentation
does not affect Drp1 dynamics. HeLa cells expressing GFP-Drp1
were treated with either vehicle (basal) or 10 mM carbonylcyanide
p-trifluoromethoxyphenylhydrazone (FCCP) and 2 mM oligomy-
cin (prevents ATP depletion due to reversal of the F1 ATP
synthase) for 1 to 4 h, during which time Drp1 turnover was
measured by FRAP. FCCP leads to dramatic mitochondrial
fragmentation as quantified by form factor (A) but has no effect on
Drp1 recovery (B, representative frames; C, average recovery
curves [6 s.e.m.] from a representative experiment).
Found at: doi:10.1371/journal.pbio.1000612.s006 (1.53 MB TIF)
Figure S7 AKAP1 enhances forskolin-stimulated Drp1 phos-
phorylation in PC12 cells. PC12 cells cotransfected with GFP-
Drp1 and either empty vector, AKAP1, or AKAP1 DPKA were
stimulated for 45 min with the indicated concentrations of
forskolin in the presence of rolipram (2 mM). Total cell lysates
were probed for phospho-SerPKA Drp1 (pDrp1) and total Drp1 on
the same blot using a dual-channel infrared imager. Drp1
phosphorylation was quantified as the ratio of phospho- to total
Drp1 signals normalized to the highest value. Shown is one
experiment representative of two.
Found at: doi:10.1371/journal.pbio.1000612.s007 (0.11 MB TIF)
Figure S8 Elongation of dendritic mitochondria by AKAP1
requires Drp1 SerPKA. Primary hippocampal neurons cotrans-
fected with wild-type or SerPKA-mutant GFP-Drp1 and either
vector, wild-type, or PKA binding-deficient (DPKA) AKAP1 were
analyzed for morphology of dendritic mitochondria after immu-
nofluorescence staining for the OMM-protein TOM20 (represen-
tative images in A). (B) and (C) show mitochondrial form factor
and length, respectively, from the same set of neurons (means 6
s.e.m. of 12–24 neurons per condition from two culture dates).
Found at: doi:10.1371/journal.pbio.1000612.s008 (0.36 MB TIF)
Video S1 AKAP1 slows Drp1 fluorescence recovery. Coexpres-
sion with AKAP1 slows recovery of GFP-Drp1 in the photo-
bleached square compared to when either protein is mutated.
Found at: doi:10.1371/journal.pbio.1000612.s009 (0.80 MB
MPG)
Video S2 A mutation in the GTPase domain slows Drp1
fluorescence recovery. FRAP kinetics of the T55D mutant are
attenuated compared to wild-type GFP-Drp1.
Found at: doi:10.1371/journal.pbio.1000612.s010 (0.89 MB
MPG)
Video S3 PKA and GTPase mutation extend the lifetime of
mitochondrial Drp1 punctae. Coexpression with the PKA catalytic
subunit or T55D substitution leads to the accumulation of large
GFP-Drp1 punctae that turn over more slowly than wild-type
Drp1 without PKA.
Found at: doi:10.1371/journal.pbio.1000612.s011 (1.87 MB
MPG)
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